ArticleCancer immunology, immunotherapy : CII2024

Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours.

Manish R Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.